The primary outcome of this computational analysis suggested that huperzine A likely influences Alzheimer’s disease through various synaptic neurotransmitter and metabolic pathways, rather than through a direct effect on acetylcholinesterase [259]. The gene discussed is ACHE; the disease is Alzheimer disease.